An Analysis of the 2014 Moroccan Drug Price Cuts.

OBJECTIVE In 2013, the Moroccan government implemented Decree 2-13-852, which introduced a major overhaul of drug-pricing policy in the country. Under the decree, the ex-manufacturer price of originator products was set at the average ex-manufacturer price from a basket of countries, including Belgium, France, Portugal, Saudi Arabia, Spain, and Turkey. Generic medicine prices could not exceed those of comparators, and the decree introduced a set price difference between generic and comparator. The extent of this difference is tied to ex-manufacturer prices of the originator (see table).